STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4132 by analyst upside · 2026-06-27
HUM
Humana Inc.
Healthcare · Market Cap $46B · P/E 40.2x
ANALYST PRICE TARGET
-20.7%
implied upside to consensus target
Current Price $383.84
Consensus Target $304.33
Bull Target $441.0
Bear Target $195.0
Analysts Covering 24
ANALYST CONSENSUS - HOLD
Strong Buy
2
Buy
5
Hold
15
Sell
2
52-Week Low $163.11
52-Week High $385.47
YTD Return +45.9%
FUNDAMENTALS
Market Cap $46B
P/E Ratio (TTM) 40.2x
Forward P/E 24.4x
EPS (TTM) $9.56
PEG Ratio 2.05
Dividend Yield 0.92%
Revenue (TTM) $137.2B
Profit Margin 0.8%
52-WEEK RANGE
52-Week Low $163.11
52-Week High $385.47
Current Price $383.84
Bear Target $195.0
Bull Target $441.0
● Now $383.84 ● Target $304.33
TRADING DATA
Avg Volume 1.7M
YTD Return +45.9%
Analyst Count 24
Consensus Hold
Upside to Target -20.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Humana Inc. (HUM) is currently trading at $383.84 with a Wall Street consensus price target of $304.33, which is 20.7% below the current price over the next 12 months. 24 analysts currently cover HUM, with a consensus rating of Hold - 29% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $441.0, while the most cautious has a target of $195.0.

HUM operates in the Healthcare sector with a market capitalisation of $46B. The stock is up 45.9% year-to-date and is currently trading near the upper end of its 52-week range of $163.11 – $385.47.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HUM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Evercore ISI Group — Reiterated
In-Line → In-Line 2026-06-11 Building track record
Mizuho — Reiterated
Outperform → Outperform 2026-06-08 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-06-08 43% win rate (7 calls)
B of A Securities — Reiterated
Neutral → Neutral 2026-06-04 Building track record
Morgan Stanley — Reiterated
Underweight → Underweight 2026-06-04 Building track record
Truist Securities — Reiterated
Hold → Hold 2026-06-01 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-05-26 Building track record
UBS — Reiterated
Neutral → Neutral 2026-05-22 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
25/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →